Pharmaceutical science to improve the human condition : winners and finalists of the Prix Galien USA 2012.
New York Academy of Sciences.
Galien Foundation.
Hoboken, N.J. : Wiley Subscription Services,
2013.
Includes bibliographical references.
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma / Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, Walter J. Urba, Caroline Robert, Steven J. O'Day, Axel Hoos, Rachel Humphrey, David M. Berman, Nils Lonberg and Alan J. Korman -- Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases / David Lebwohl, Özlem Anak, Tarek Sahmoud, Judith Klimovsky, Ingrid Elmroth, Tomas Haas, Joseph Posluszny, Stephen Saletan and William Berg -- Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic / Pamela Sears, Yoshi Ichikawa, Nancy Ruiz and Sherwood Gorbach -- Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection / Daria J. Hazuda, Margaret Burroughs, Anita Y.M. Howe, Janice Wahl and Srikanth Venkatraman -- Tumor treating fields: a new frontier in cancer therapy / Angela M. Davies, Uri Weinberg and Yoram Palti -- The Berlin Heart EXCOR Pediatric ventricular assist device: history, North American experience, and future directions / Charles D. Fraser Jr. and Robert D.B. Jaquiss.
Pharmacology.
Pharmaceutical industry.
Research.
Current copyright fee: GBP22.00